Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,066 | 472 | 99.5% |
| Education | $32.17 | 5 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $798.83 | 58 | $0 (2023) |
| Novo Nordisk Inc | $769.50 | 56 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $714.53 | 53 | $0 (2021) |
| Amgen Inc. | $620.27 | 43 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $578.10 | 37 | $0 (2024) |
| ABBVIE INC. | $350.51 | 23 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $344.12 | 25 | $0 (2023) |
| PFIZER INC. | $305.51 | 18 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $253.61 | 17 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $228.04 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $183.10 | 11 | AstraZeneca Pharmaceuticals LP ($49.90) |
| 2023 | $527.63 | 28 | Lilly USA, LLC ($85.10) |
| 2022 | $855.34 | 55 | Bayer HealthCare Pharmaceuticals Inc. ($163.16) |
| 2021 | $1,063 | 67 | Lilly USA, LLC ($153.97) |
| 2020 | $729.34 | 48 | Amgen Inc. ($160.56) |
| 2019 | $1,072 | 70 | Novo Nordisk Inc ($179.08) |
| 2018 | $1,066 | 80 | Novo Nordisk Inc ($252.27) |
| 2017 | $1,602 | 118 | Janssen Pharmaceuticals, Inc ($384.09) |
All Payment Transactions
477 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.98 | General |
| 11/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Inflammation | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $19.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/20/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Biological | ||||||
| 08/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Inflammation | ||||||
| 08/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Diabetes | ||||||
| 04/01/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.08 | General |
| 03/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Cardio-renal | ||||||
| 02/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: TEPEZZA | ||||||
| 11/03/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/31/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Diabetes | ||||||
| 09/07/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Oncology | ||||||
| 07/21/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Diabetes | ||||||
| 07/19/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/26/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $29.42 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 06/22/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Diabetes | ||||||
| 06/13/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Cardio-renal | ||||||
| 06/09/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: PSYCHIATRY | ||||||
| 06/06/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 465 | 819 | $186,240 | $47,788 |
| 2022 | 8 | 550 | 947 | $171,728 | $54,027 |
| 2021 | 9 | 463 | 917 | $123,004 | $52,292 |
| 2020 | 10 | 430 | 777 | $89,387 | $34,733 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 85 | 204 | $54,468 | $14,887 | 27.3% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 74 | 161 | $32,966 | $8,023 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 86 | $31,390 | $7,277 | 23.2% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 69 | 74 | $26,480 | $7,086 | 26.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 81 | $20,898 | $4,541 | 21.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 23 | 23 | $8,579 | $2,763 | 32.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 32 | 62 | $9,155 | $2,206 | 24.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 70 | 114 | $2,052 | $957.60 | 46.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 13 | 14 | $252.00 | $47.74 | 18.9% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 86 | 206 | $55,002 | $13,830 | 25.1% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 96 | 108 | $20,088 | $10,351 | 51.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 54 | 115 | $30,197 | $9,592 | 31.8% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 62 | 115 | $22,770 | $5,841 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 85 | $10,700 | $4,395 | 41.1% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 54 | 81 | $14,580 | $4,321 | 29.6% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 37 | 52 | $7,280 | $1,855 | 25.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 15 | 15 | $4,986 | $1,832 | 36.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 34 | 43 | $3,838 | $1,634 | 42.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 72 | 127 | $2,286 | $376.11 | 16.5% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 98 | 282 | $50,760 | $18,501 | 36.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 53 | 108 | $16,440 | $9,319 | 56.7% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2021 | 82 | 94 | $17,486 | $9,108 | 52.1% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 64 | 160 | $22,400 | $7,513 | 33.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 40 | 73 | $7,557 | $4,274 | 56.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 24 | 24 | $4,016 | $3,000 | 74.7% |
About Dr. John Johnson, MD
Dr. John Johnson, MD is a Internal Medicine healthcare provider based in Batesville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790709103.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Johnson, MD has received a total of $7,098 in payments from pharmaceutical and medical device companies, with $183.10 received in 2024. These payments were reported across 477 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($7,066).
As a Medicare-enrolled provider, Johnson has provided services to 1,908 Medicare beneficiaries, totaling 3,460 services with total Medicare billing of $188,840. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Batesville, IN
- Active Since 07/27/2006
- Last Updated 11/20/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1790709103
Products in Payments
- XARELTO (Drug) $526.51
- FARXIGA (Drug) $424.60
- TRULICITY (Drug) $371.64
- Aimovig (Biological) $306.12
- Ozempic (Drug) $294.56
- Victoza (Drug) $265.36
- VRAYLAR (Drug) $264.37
- JARDIANCE (Drug) $252.84
- Kerendia (Drug) $228.04
- XIFAXAN (Drug) $210.99
- INVOKANA (Drug) $182.00
- ELIQUIS (Drug) $166.32
- Vascepa (Drug) $150.63
- Korlym (Drug) $143.95
- EMGALITY (Drug) $138.73
- ARISTADA (Drug) $132.18
- Otezla (Drug) $131.38
- Repatha (Biological) $120.32
- JANUVIA (Drug) $120.02
- TOUJEO (Drug) $101.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Batesville
Dr. Kamarajapuram Desikan, M.d, M.D
Internal Medicine — Payments: $16,144
Charles Webster, Md, MD
Internal Medicine — Payments: $2,853
Anup Singh, Md, MD
Internal Medicine — Payments: $2,034
Dr. Johnnie Cummings, M.d, M.D
Internal Medicine — Payments: $1,662
Dr. Sarah Luebker, Do, DO
Internal Medicine — Payments: $1,604
Robert Walton, Md, MD
Internal Medicine — Payments: $633.09